Skip to main content
BMC is moving to Springer Nature Link. Visit this journal in its new home.

Peer Review reports

From: PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer

Original Submission
3 Mar 2025 Submitted Original manuscript
31 Mar 2025 Author responded Author comments - Aleksandra Pawlak
Resubmission - Version 2
7 Apr 2025 Submitted Manuscript version 2
7 Apr 2025 Author responded Author comments - Aleksandra Pawlak
13 May 2025 Reviewed Reviewer Report
15 May 2025 Reviewed Reviewer Report
Resubmission - Version 3
1 Jun 2025 Submitted Manuscript version 3
1 Jun 2025 Author responded Author comments - Aleksandra Pawlak
Resubmission - Version 4
15 Jun 2025 Submitted Manuscript version 4
15 Jun 2025 Author responded Author comments - Aleksandra Pawlak
Publishing
16 Jun 2025 Editorially accepted
5 Jul 2025 Article published 10.1186/s12917-025-04880-z

You can find further information about peer review here.

Back to article page